The London-listed firm had to pause global trials of its potential vaccine for COVID-19 after an unexplained illness in a participant, which sent its shares lower as the move was seen as dimming prospects for an early rollout.AstraZeneca did not immediately respond to a Reuters request for comment.
AstraZeneca coronavirus vaccine trials could resume next week – report
By REUTERS
11/25/2024 05:43 PM
By REUTERS
11/25/2024 04:05 PM
By MAARIV
11/25/2024 01:58 PM
By REUTERS
11/25/2024 01:17 PM
By REUTERS
11/25/2024 12:24 PM
By REUTERS
11/25/2024 11:45 AM